Oral anticoagulation control: The European perspective

Journal of Thrombosis and Thrombolysis

Volumn 21, Issue 1, 2006, Pages 95-100

  Fitzmaurice, David A ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

INR; Oral anticoagulation; Point of care testing

Indexed keywords

ANTICOAGULANT AGENT; WARFARIN;

ANTICOAGULANT THERAPY; ANTICOAGULATION; BLEEDING; COMPUTER PROGRAM; COST EFFECTIVENESS ANALYSIS; COST OF ILLNESS; DECISION SUPPORT SYSTEM; DRUG EFFICACY; DRUG SAFETY; ECONOMIC EVALUATION; EUROPE; EVIDENCE BASED MEDICINE; HEALTH CARE COST; HEALTH CARE DELIVERY; HUMAN; INTERNATIONAL NORMALIZED RATIO; NURSE; OUTCOMES RESEARCH; PATIENT CARE; PATIENT MONITORING; POINT OF CARE TESTING; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; REVIEW; STAFF TRAINING; SYSTEMATIC REVIEW; UNITED KINGDOM; VENOUS THROMBOEMBOLISM;

ANTICOAGULANTS; DRUG MONITORING; FEMALE; GREAT BRITAIN; HUMANS; INTERNATIONAL NORMALIZED RATIO; MALE;

EID: 32544442830     PISSN: 09295305     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11239-006-5584-7     Document Type: Review

References (29)

1. Sweeney KG, Pereira-Gray D, Steele R, Evans P. Use of warfarin in non-rheumatic atrial fibrillation: A commentary from general practice. British Journal of General Practice 1995;45:153-158.
2. Lowe GDO, Anti-thrombotic treatment and atrial fibrillation. Editorial. BMJ 1992;305;1445-1446.
3. Sudlow CM, Rodgers H, Kenny RA, Thomson RG. Service provision and use of anticoagulants in atrial fibrillation. BMJ 1995;311:558-561.
4. Sudlow M, Rodgers H, Kenny RA, Thomson R. Population based study of use of anticoagulants among patients with atrial fibrillation in the community. BMJ 1997;314:1529-1530.
5. Shakespeare J. Anticoagulation in patients with atrial fibrillation. GPs struggle to meet demand. BMJ 1994;308: 415.
6. Fitzmaurice DA, Hobbs FDR, Murray ET, Bradley CP, Holder R. Evaluation of computerized decision support for oral anticoagulation management in primary care. British Journal of General Practice 1996;46:533-535.
7. Ryan P, Gilbert M, Rose PE. Computer control of anti-coagulant dose for therapeutic management. BMJ 1989; 299:1207-1209.
8. Hobbs FDR. Near patient testing in primary care. BMJ 1996;312:263-264.
9. Oberhardt BJ, Dermott SC, Taylor M, Alkadi ZY, Abruzzini AF, Gresalfi NJ. Dry reagent technology for rapid, convenient measurements of blood coagulation and fibrinolysis. Clin Chem 1991;37:520-526.
10. Palareti G, Leali N, Coccheri S, et al. Bleeding complications of oral anticoagulant treatment: An inception-cohort, prospective collaborative study (ISCOAT). Lancet 1996;348:423-428.
11. Fihn SD, McDonell M, Martin D, et al. Risk factors for complications of chronic anticoagulation. Ann Intern Med 1993:118:511-520.
12. van der Meer FJM, Rosendaal FR, Vandenbroucke Briet E. Bleeding complication in oral anticoagulant therapy. Arch Intern Med 1993:153:1557-1562.
13. Sawicki PT. A structured teaching and self-management program for patients receiving oral anticoagulation. A randomized controlled trial. JAMA 1999:281;145-150.
14. White R, McCurdy SA, von Marensdorff H, Woodruff DE, Leftgoff PA. Home prothrombin time monitoring after the initiation of Warfarin therapy. Ann Intern Med 1989;111:9:730-736.
15. Korfer R, Kortke H. ESCAT Early Self Controlled Anticoagulation Trial. Annals of Thoracic Surgery 2001;72:44-48.
16. Cromheecke ME, Levi M, Colly LP, et al. Oral anticoagulation self-management by a specialist anticoagulation clinic: A randomized cross-over comparison. Lancet 2000; 356:97-102.
17. Sidhu P, O'Kane HO. Self-managed anticoagulation: Results from a two-year prospective randomized trial with heart valve patients. Annals of Thoracic Surgery 2001; 72:1523-1527.
18. Hasenkam JM, Kimose HH, Knudsen L, et al. Self management of oral anticoagulation therapy after heart valve replacement; European Journal of Cardio-Thoracic Surgery 1997;11:935-942.
19. Ansell JE, Patel N, Ostrovsky D, Nozzolillo E, Peterson AM. Long term patient self management of oral anticoagulation. Arch Intern Med 1995;155:2185-2189.
20. Cosmi B, Palareti G, Carpanedo M, et al. Assessment of patient capability to self-adjust oral anticoagulant dose: A multicenter study on home use of portable prothrombin time monitor (COAGUCHEK). Haematologica 2000;85: 826-831.
21. Anderson DR, Harrison L, Hirsh J. Evaluation of a portable prothrombin time monitor for home use by patients who require long-term oral anticoagulant therapy. Arch Intern Med 1993;153:1441-1447.
22. Bernardo A. Experience with patient self-management of oral anticoagulation. J Thrombosis and Thrombolysis 1995;2:321-325.
23. Massicotte P, Marzinotto V, Vegh P, Adams M, Andrew M. Home monitoring of warfarin therapy in children with a whole blood monitor. The Journal of Paediatrics 1995;127:389-394.
24. Stamper G, Toth P. Patient self testing for Prothrombin time using the Coaguchek system - a feasibility study; Clinical chemistry 1996;42:6;10.1-10.7.
25. Lucas FV, Duncan A, Jay R, et al. A novel whole blood capillary technic for measuring the prothrombin time. Am J Clin Path 1987;88:442-446.
26. Van den Besselar AMHP, Breddin K, Parker-Williams, et al. Multicenter evaluation of a new capillary blood prothrombin time monitoring system. Blood Coagul Fibrinolysis 1995;6:726-732.
27. Taborski VWE, Wittstamm FJ, Bernardo A. Cost-effectiveness of self-management anticoagulant therapy in Germany. Seminars in Thrombosis and Haemostasis 1999;25:10-107.
28. Fitzmaurice DA, Murray ET, Gee KM, Allan TF, Hobbs FDR. A randomized controlled trial of patient self-management of oral anticoagulation treatment compared with primary care management. J Clin Pathol 2002;55:845-849.
29. Fitzmaurice DA, Murray ET, Hobbs FDR, MacCahon. Self-management of anticoagulation: A randomized trial. BJ Haem 2004;125(Suppl 1):56.